Carolyn Barber, MD on Nostr: In the U.S., Alzheimer's drug Leqembi has a list price of $26,500 ($740 in UK). ...

In the U.S., Alzheimer's drug Leqembi has a list price of $26,500 ($740 in UK).

Though the FDA greenlighted Leqembi here, EU regulators called for the medicine to be rejected there, stating that its benefits didn't outweigh the risks.

A key concern is ARIA, a brain swelling or bleeding that can be fatal in rare cases.
⭐️In a trial, 1 OUT OF 5 experienced ARIA, but <3% were symptomatic.
⭐️Two patients died of serious brain bleeds in an extension of the study.

"The benefits are very 1/2